Central Nervous System Leptomeningeal Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-08-01
Clinical Trial Update: 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
Clinical trial NCT05064306 evaluating 131I-omburtamab for central nervous system leptomeningeal neoplasms in children and young adults is no…